| Product Code: ETC8566237 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, New Zealand`s ophthalmology drugs and devices import market continued to see steady growth, with the top exporting countries being the USA, Australia, Metropolitan France, Germany, and Ireland. The market remains relatively diverse with low concentration, as indicated by the low Herfindahl-Hirschman Index (HHI). Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-2024 was a robust 6.71%, pointing towards a promising outlook for the industry in New Zealand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Ophthalmology Drugs and Devices Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 New Zealand Ophthalmology Drugs and Devices Market - Industry Life Cycle |
3.4 New Zealand Ophthalmology Drugs and Devices Market - Porter's Five Forces |
3.5 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Products, 2022 & 2032F |
3.6 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.7 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 New Zealand Ophthalmology Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye diseases and disorders in New Zealand |
4.2.2 Growing aging population leading to a higher demand for ophthalmology drugs and devices |
4.2.3 Technological advancements in ophthalmic treatments and devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of ophthalmology drugs and devices |
4.3.2 High cost associated with advanced ophthalmic treatments and devices |
4.3.3 Limited accessibility and affordability of specialized ophthalmic care in certain regions of New Zealand |
5 New Zealand Ophthalmology Drugs and Devices Market Trends |
6 New Zealand Ophthalmology Drugs and Devices Market, By Types |
6.1 New Zealand Ophthalmology Drugs and Devices Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Products, 2022 - 2032F |
6.1.3 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Diagnostic and Monitoring Devices, 2022 - 2032F |
6.1.4 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Surgical Devices, 2022 - 2032F |
6.1.5 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Vision Care, 2022 - 2032F |
6.1.6 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Drugs, 2022 - 2032F |
6.2 New Zealand Ophthalmology Drugs and Devices Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Glaucoma, 2022 - 2032F |
6.2.3 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Retinal disorders, 2022 - 2032F |
6.2.4 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Dry eye, 2022 - 2032F |
6.2.5 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Allergy/Inflammation/Conjunctivitis, 2022 - 2032F |
6.3 New Zealand Ophthalmology Drugs and Devices Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.3.3 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.3.4 New Zealand Ophthalmology Drugs and Devices Market Revenues & Volume, By Others, 2022 - 2032F |
7 New Zealand Ophthalmology Drugs and Devices Market Import-Export Trade Statistics |
7.1 New Zealand Ophthalmology Drugs and Devices Market Export to Major Countries |
7.2 New Zealand Ophthalmology Drugs and Devices Market Imports from Major Countries |
8 New Zealand Ophthalmology Drugs and Devices Market Key Performance Indicators |
8.1 Number of clinical trials conducted for new ophthalmology drugs and devices in New Zealand |
8.2 Adoption rate of innovative ophthalmology treatments and devices in the market |
8.3 Percentage of population receiving regular eye screenings and examinations |
8.4 Rate of utilization of telemedicine services for ophthalmic consultations |
9 New Zealand Ophthalmology Drugs and Devices Market - Opportunity Assessment |
9.1 New Zealand Ophthalmology Drugs and Devices Market Opportunity Assessment, By Products, 2022 & 2032F |
9.2 New Zealand Ophthalmology Drugs and Devices Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.3 New Zealand Ophthalmology Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 New Zealand Ophthalmology Drugs and Devices Market - Competitive Landscape |
10.1 New Zealand Ophthalmology Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 New Zealand Ophthalmology Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here